R&D Systems Recombinant Human BCAT1 Protein CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9536BA020
DescriptionThe Recombinant Human BCAT1 Protein is derived from E. coli. The Recombinant Human BCAT1 Protein has been validated for the following applications: Enzyme Activity.
|>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|E. coli-derived Lys2-Ser386 with an N-terminal Met and 6-His tag|
|<0.10EU per 1μg of the protein by the LAL method.|
|Supplied as a 0.2μm filtered solution in Tris, NaCl, DTT and Glycerol.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening.|
|BCAT(c), BCAT-1, BCATC, BCT1, BCT1PNAS121, branched chain amino-acid transaminase 1, cytosolic, branched chain aminotransferase 1, cytosolic, branched-chain-amino-acid aminotransferase, cytosolic, DKFZp686E12175, EC 18.104.22.168, ECA39, MECA39, placental protein 18, PNAS121, PP18, Protein ECA39|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok